KADIMA, Israel, Nov. 21, 2023 /PRNewswire/ -- William (Bill) Hoffman has joined Magenta Medical's Board of Directors as an independent industry expert. Magenta Medical is developing the Elevate™ System, the smallest heart pump in the world.Mr. Hoffman currently serves as a member of the board of directors of Inari Medical, where he was CEO from 2015 until 2022.

以色列卡迪玛，2023年11月21日/PRNewswire/-威廉（比尔）霍夫曼已加入洋红色医疗的董事会担任独立行业专家。洋红色医学正在发展升高™ 系统，世界上最小的心脏泵。Hoffman先生目前是Inari Medical董事会成员，他在2015年至2022年期间担任首席执行官。

In May 2020, he led the company to a successful IPO. Prior to Inari Medical, Mr. Hoffman served as CEO of Visualase, Inc., and VP of Sales at FoxHollow Technologies, acquired by Medtronic and ev3, respectively..

2020年5月，他带领该公司成功IPO。在Inari Medical之前，Hoffman先生曾担任Visualase，Inc.的首席执行官和FoxHollow Technologies的销售副总裁，分别由Medtronic和ev3收购。。

Continue Reading

继续阅读

Mr. William (Bill) Hoffman, Independent Director, Magenta Medical Ltd.

威廉先生（比尔）霍夫曼，洋红色医疗有限公司独立董事。

'Magenta is developing a next-generation temporary mechanical circulatory support system that addresses the important shortcomings of current systems around insertion size and flow. The team is mission-driven, and I love their commitment to treat underserved populations, improve patient outcomes, and save lives,' said Mr.

“洋红色正在开发下一代临时机械循环支持系统，解决当前系统在插入尺寸和流量方面的重要缺点。该团队是使命驱动的，我喜欢他们致力于治疗服务不足的人群，改善患者预后并挽救生命，“先生说。

Hoffman..

霍夫曼。。

'Bill Hoffman is a widely respected and accomplished leader in the MedTech industry. The company is certain to benefit from his experience and insights as it looks to achieve its upcoming clinical milestones and future commercial goals,' said Dr. David Israeli, CEO of Magenta Medical.About Elevate™The Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) is a miniaturized heart pump that fits a 9 Fr delivery system, providing the smallest crimping profile in the industry.

“比尔·霍夫曼（Bill Hoffman）是MedTech行业广受尊重和成就的领导者。洋红色医学首席执行官David Israeli博士说，该公司肯定会从他的经验和见解中受益，因为它有望实现即将到来的临床里程碑和未来的商业目标。关于提升™提升™ 经皮左心室辅助装置（pLVAD）是一种小型心脏泵，适合9 Fr输送系统，在行业中提供最小的卷曲曲线。

The ElevateTM Pump can be inserted over a guidewire, using a 10 Fr commercially available femoral introducer sheath. The flow of the pump is adjusted based on the clinical circumstances of the patient and can exceed 5 L/min of mean flow. This makes it the most powerful device of its kind.Elevate™ is an investigational device, limited by federal law to investigational use only.

可以使用10Fr市售股骨导引鞘将ElevateTM泵插入导丝上。根据患者的临床情况调整泵的流量，并且可以超过5L/min的平均流量。这使其成为同类产品中功能最强大的设备。提升™ 是一种研究设备，仅限于联邦法律的研究用途。

The technology was awarded Breakthrough Device Designation from the US Food and Drug Administration (FDA) for two indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock.About Magenta MedicalMagenta Medical Ltd. is a privately-held company dedicated to the development of miniaturized blood pumps intended to provide minimally-invasive support to the native heart during acute episodes of dysfunction that could lead to dangerously low blood pressure and compromised perfusion of vital organs.

该技术获得了美国食品和药物管理局（FDA）的突破性设备指定，用于两种适应症：高风险经皮冠状动脉介入治疗（HR-PCI）和心源性休克。关于Magenta MedicalMagenta Medical Ltd.是一家私营公司，致力于开发小型血泵，旨在在急性功能障碍发作期间为原生心脏提供微创支持，这可能导致危险的低血压和重要器官灌注受损。

Magenta's Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) is currently in clinical trials to be evaluated for at least two indications: patients undergoing high-risk percutaneous coronary interventions (HR-PCI) and patients with cardiogenic shock.For more information, please visit https://magentamed.com/Media ContactMarjie HadadGeneral ManagerMust Have Communications[email protected]+972 (54) .

洋红色的升高™ 经皮左心室辅助装置（pLVAD）目前正在进行临床试验，以评估至少两种适应症：接受高风险经皮冠状动脉介入治疗（HR-PCI）的患者和心源性休克患者。欲了解更多信息，请访问https://magentamed.com/MediaContactMarjie HadadGeneral ManagerMust拥有通信[电子邮件保护]+972（54）。